We are live on ! Find out more
UNH icon

UnitedHealth

1,965 hedge funds and large institutions have $201B invested in UnitedHealth in 2019 Q2 according to their latest regulatory filings, with 147 funds opening new positions, 897 increasing their positions, 720 reducing their positions, and 104 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 147 | Existing positions closed: 104

25% more repeat investments, than reductions

Existing positions increased: 897 | Existing positions reduced: 720

1% more funds holding

Funds holding: 1,9441,965 (+21)

1% more call options, than puts

Call options by funds: $1.68B | Put options by funds: $1.66B

0.69% more ownership

Funds ownership: 86%86.69% (+0.69%)

1% less capital invested

Capital invested by funds: $204B → $201B (-$2.56B)

15% less funds holding in top 10

Funds holding in top 10: 176149 (-27)

Holders
1,965
Holders Change
+21
Holders Change %
+1.08%
% of All Funds
42.67%
Holding in Top 10
149
Holding in Top 10 Change
-27
Holding in Top 10 Change %
-15.34%
% of All Funds
3.24%
New
147
Increased
897
Reduced
720
Closed
104
Calls
$1.68B
Puts
$1.66B
Net Calls
+$15.9M
Net Calls Change
-$66M
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
301
Dupont Capital Management
Delaware
$34.5M -$3.82M -15,872 -10%
VanEck Associates
302
VanEck Associates
New York
$34.4M +$29.4M +122,293 +649%
PI
303
PineBridge Investments
New York
$34.4M +$7.55M +31,407 +29%
IC
304
Inverness Counsel
New York
$33.7M -$10.2M -42,303 -23%
WA
305
WestEnd Advisors
North Carolina
$33.3M -$1.55M -6,453 -5%
MSA
306
Mason Street Advisors
Wisconsin
$33.1M -$326K -1,356 -1%
MIS
307
Morningstar Investment Services
Illinois
$32.8M +$2.24M +9,326 +7%
FAF
308
Första AP-fonden
Sweden
$32.7M +$32.2M +133,900 New
HIMCH
309
Hartford Investment Management Co (HIMCO)
Connecticut
$32.4M -$58.4K -243 -0.2%
SMDAM
310
Sumitomo Mitsui DS Asset Management
Japan
$32.1M -$50.6M -210,178 -62%
SOADOR
311
State of Alaska Department of Revenue
Alaska
$31.8M -$715K -2,971 -2%
MIFH
312
Migdal Insurance & Financial Holdings
Israel
$31.6M +$30.9M +128,677 +15,032%
NAM
313
Nissay Asset Management
Japan
$31.6M -$4.61M -19,158 -13%
AAM
314
Ardevora Asset Management
United Kingdom
$31.5M +$3.34M +13,900 +12%
BIM
315
Bridges Investment Management
Nebraska
$31.2M +$1.87M +7,778 +6%
NAM
316
NorthCoast Asset Management
Connecticut
$31.2M +$2.29M +9,537 +8%
Northwestern Mutual Wealth Management
317
Northwestern Mutual Wealth Management
Wisconsin
$31.1M -$628K -2,611 -2%
SCP
318
Steamboat Capital Partners
New York
$30.9M +$8.97M +37,289 +42%
DILIC
319
Dai-ichi Life Insurance Company
Japan
$30.9M -$4.67M -19,424 -13%
AB
320
Amalgamated Bank
New York
$30.7M -$4.53M -18,817 -13%
ZIM
321
Zacks Investment Management
Illinois
$30.5M -$2.36M -9,814 -7%
TAM
322
Todd Asset Management
Kentucky
$30.3M -$18.1M -75,359 -38%
PIA
323
Piedmont Investment Advisors
North Carolina
$30M -$376K -1,564 -1%
CG
324
Colony Group
Massachusetts
$29.6M +$1.51M +6,263 +5%
OCAM
325
Onex Canada Asset Management
Ontario, Canada
$29.5M -$521K -2,165 -2%

UNH Hedge Fund Activity: Q2 2019 in Review

1,965 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in UnitedHealth (UNH) for Q2 2019, worth a combined $201B — down 1.3% from $204B a quarter earlier.

Buyers outnumbered sellers: 147 funds opened new UNH positions and 104 closed out — a net gain of 43 holders — while 897 added to existing stakes and 720 trimmed.

The largest buyer was Nuveen, adding an estimated $1.91B. The largest seller was T. Rowe Price Associates, cutting an estimated $2.27B.

  • 1,965 institutional investors held UnitedHealth (UNH) as of Q2 2019, up from 1,944 in Q1 2019.
  • Funds reported $201B of UnitedHealth stock for Q2 2019, down 1.3% quarter-over-quarter.
  • 147 funds opened new UnitedHealth positions in Q2 2019 and 104 closed out, a net change of +43 holders.
  • The largest UnitedHealth buyer in Q2 2019 was Nuveen, an estimated $1.91B added.
  • The largest UnitedHealth seller in Q2 2019 was T. Rowe Price Associates, an estimated $2.27B sold.

Based on aggregated 13F filings for Q2 2019.